Eternox Overview

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 3

Eternox General Information

Description

Operator of a biotechnology company developing therapies to remove reactive oxygen species for the treatment of septic shock. The company specializes in extracorporeal removal of reactive oxygen species, incorporating selective adsorption materials, compatibility with existing critical care blood circulation systems, and use in refractory septic shock supported by preclinical animal survival data, targeting reduction of oxidative injury and inflammatory escalation, enabling intensive care units and hospitals treating severe sepsis to address high mortality where current pharmacologic interventions show limited effectiveness.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Seoul
  • South Korea
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • Seoul
  • South Korea

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Eternox Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 01-Jan-2026 Completed Startup
To view Eternox’s complete valuation and funding history, request access »

Eternox Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Asia2G Capital Venture Capital Minority
FuturePlay Venture Capital Minority
Schmidt (South Korea) Venture Capital Minority
To view Eternox’s complete investors history, request access »

Ready to get started?

Request a free trial

Eternox FAQs

  • Where is Eternox headquartered?

    Eternox is headquartered in Seoul, South Korea.

  • What industry is Eternox in?

    Eternox’s primary industry is Biotechnology.

  • Is Eternox a private or public company?

    Eternox is a Private company.

  • What is Eternox’s current revenue?

    The current revenue for Eternox is .

  • Who are Eternox’s investors?

    Asia2G Capital, FuturePlay, and Schmidt (South Korea) have invested in Eternox.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process